<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03553511</url>
  </required_header>
  <id_info>
    <org_study_id>LULS-1</org_study_id>
    <nct_id>NCT03553511</nct_id>
  </id_info>
  <brief_title>Laparoscopic Hysterectomy With Vaginal Vault Suspension to the Uterosacral Ligaments for Stage II-III Pelvic Organ Prolapse.</brief_title>
  <acronym>LULS-1</acronym>
  <official_title>Short and Long-term Outcomes After Total Laparoscopic Hysterectomy With Vaginal Vault Suspension to the Uterosacral Ligaments Versus Vaginal Hysterectomy With McCall Culdoplasty for the Treatment of Stage II-III Pelvic Organ Prolapse.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The International Continence Society defines post-hysterectomy vault prolapse (PHVP) as&#xD;
      descent of the vaginal cuff scar below a point that is 2 cm less than the total vaginal&#xD;
      length above the plane of the hymen. The incidence of PHVP has been reported to affect up to&#xD;
      43% of hysterectomies. The risk of prolapse following hysterectomy is 5.5 times more common&#xD;
      in women whose initial hysterectomy was for pelvic organ prolapse as opposed to other&#xD;
      reasons.&#xD;
&#xD;
      Techniques available to manage PHVP aim to ultimately suspend the vaginal vault. Approaches&#xD;
      include vaginal, e.g. uterosacral ligament suspension, sacrospinous ligament fixation, open&#xD;
      procedures and more recently laparoscopic, e.g. sacrocolpopexy and uterosacral plication.&#xD;
&#xD;
      Data published so far do not allow to draw a firm conclusion about the best treatment to&#xD;
      prevent PHVP for women undergoing hysterectomy for stage II-III pelvic organ prolapse.&#xD;
      Considering this scenario, in the current study the investigators aim to evaluate short and&#xD;
      long-term outcomes after total laparoscopic hysterectomy with vaginal vault suspension to the&#xD;
      uterosacral ligaments versus vaginal hysterectomy with McCall culdoplasty for the treatment&#xD;
      of stage II-III pelvic organ prolapse.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2022</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective Randomized Clinical trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Vaginal vault prolapse</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary impact questionnaire score (total score minimum: 0, maximum: 100)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of urinary symptoms and signs on the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse Impact Questionnaire (total score minimum: 0, maximum: 100)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of prolapse-related symptoms and signs on the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal-Anal Impact questionnaire (total score minimum: 0, maximum: 100)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of prolapse-related colorectal and anal symptoms and signs on the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse/urinary incontinence sexual questionnaire score (total score minimum: 0, maximum: 48)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>A specific questionnaire developed to investigate the impact of prolapse/urinary incontinence on sexual functions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Uterosacral ligaments suspension</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women affected by stage II-III pelvic organ prolapse undergoing total laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>McCall culdoplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women affected by stage II-III pelvic organ prolapse undergoing vaginal hysterectomy with McCall culdoplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vaginal vault suspension to the uterosacral ligaments</intervention_name>
    <description>Laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments</description>
    <arm_group_label>Uterosacral ligaments suspension</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>McCall culdoplasty</intervention_name>
    <description>Vaginal hysterectomy with McCall culdoplasty</description>
    <arm_group_label>McCall culdoplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stage II-III pelvic organ prolapse&#xD;
&#xD;
          -  Bilateral preservation of the ovaries&#xD;
&#xD;
          -  Sexually active women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Body Mass Index &gt; 30&#xD;
&#xD;
          -  Strenuous activity (frequent heavy lifting)&#xD;
&#xD;
          -  Other gynecological and non-gynecological (chronic endocrine, metabolic, autoimmune,&#xD;
             neoplastic diseases) comorbidities&#xD;
&#xD;
          -  Pharmacological and/or nonpharmacological treatment (including pelvic floor exercises)&#xD;
             in the six months preceding the surgery or during the study period&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Simone Laganà, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jvan Casarin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonella Cromi, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabio Ghezzi, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Simone Laganà, M.D.</last_name>
    <phone>3296279579</phone>
    <phone_ext>+39</phone_ext>
    <email>antoniosimone.lagana@asst-settelaghi.it</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 30, 2018</study_first_submitted>
  <study_first_submitted_qc>May 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Antonio Simone Laganà</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Laparoscopy</keyword>
  <keyword>Hysterectomy</keyword>
  <keyword>Uterosacral ligaments suspension</keyword>
  <keyword>McCall culdoplasty</keyword>
  <keyword>Post-hysterectomy vault prolapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

